期刊文献+

非瓣膜性持续心房颤动患者抗血栓治疗临床调查 被引量:3

Clinical Investigation of Anti-thrombo Therapy on Patients With Nonvalvular Persistent Atrial Fibrillation.
下载PDF
导出
摘要 对我院从1997年1月至2002年12月住院的535例非瓣膜性持续心房颤动(简称房颤)患者病历资料进行逐项调查,分析房颤病因、抗血栓治疗及并发血栓栓塞性疾病情况.结果:病因以高血压最常见(38.5%),其次为冠心病(34.6%).使用华法令52例(9.7%),维持INR在2.0~3.0范围,无1例出现血栓栓塞性疾病及严重出血.使用阿斯匹林331例(61.9%),用量为平均75 mg/d出现血栓栓塞性疾病76例(占23%).未使用任何抗血栓治疗者152例(28.4%),出现血栓栓塞性疾病36例(23.7%).结论 :华法令能明显减少房颤相关血栓栓塞性疾病的发生,小剂量阿斯匹林则无此作用. Five hundred and thirty-five cases with nonvalvular persistent atrial fibrillation from January 1997 to December 2002 in our hospital were retrospectively analyzed on the cause of atrial fibrillation, effect of anti-thrombo therapy and occurrence of thrombo-embolism. Results :52 cases (9.7%) were treated with warfarin and maintained the international rate (INR) at 2.0 - 3.0 and nobody showed the symptom of thrombo-embolism and serious bleeding. While in 331 cases ( 61. 9% ) treated with aspirin ( avreaging 75 mg/d) and 152 cases ( 28.4% ) without use anti-thrombo therapy, thrombo-embolism was found in 76 (23%) and 36 (23.7%) patients respectively. Conclusion: Warfarin can significantly reduce the incidence of atrial fibrillation affiliated thrombo-embolism , while aspirin(75mg/d) can not prevent the occurrence of atrial fibrillation affiliated thrombo-embolism. [ Chinese Journal of Cardiac Pacing and Electrophysiology,2005,19 (5) :351 - 352 ]
作者 周红卫
出处 《中国心脏起搏与心电生理杂志》 2005年第5期351-352,共2页 Chinese Journal of Cardiac Pacing and Electrophysiology
关键词 心血管病学 非瓣膜性持续心房颤动 血栓栓塞 华法令 阿斯匹林 Cardiology Nonvalvular persistent atrial fibrillation Thrombo.embolism Warfarin Aspirin
  • 相关文献

参考文献6

  • 1William MF,Joseph LB,Andreas L,et al. Prevalence, age, distribution, and gender of patients with atrial fibrillation[J].Arch Intern Med,1995,155:469
  • 2Wolf PA,Abbott RD,Kannel WB.Atrial fibrillation as an independent risk factor for stroke:The Framingham study[J].Stroke,1991,22(2):983
  • 3杜昕,胡荣,康俊萍,韩智红,刘晓惠,董建增,马长生.心房颤动门诊病例的调查[J].中国心脏起搏与心电生理杂志,2004,18(6):438-440. 被引量:4
  • 4Femberg CD,pasty BM,Manolio TA,et al.Prevalence of atrial fibrillation in elderly subjects (The Cardiovascular Health Study)[J]. Am J Cardiol,1994,74:238
  • 5Petersen P,Boysen G,Godfredsen J,et al.The Copenhagen AFASAK Study[J]. Lancet, 1989,1:175
  • 6葛堪忆,曾辉,佘飞.540例持续性心房颤动患者华法林抗凝治疗安全性的临床观察[J].中国心脏起搏与心电生理杂志,2004,18(6):435-437. 被引量:9

二级参考文献10

  • 1Robert GH,David GS,Easton JD,et al.Prevention of stroke in patients with nonvalvular atrial fibrillation[J].Neurology,1998, 51: 674
  • 2Yamaguchi T.Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation[J]. Stroke,2000,31: 817
  • 3SPAF Ⅲ Writing Committee for the Stroke Provention in Atrial Fibrillation Investigatiors. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke prevention in atrial fibrillation Ⅲ[J] JAMA,1998,279:1 273
  • 4Fuster V, Ryde'n LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) [J]. Eur Heart J, 2001, 22: 1 852
  • 5Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates[J]. Am J Cardiol, 1998,82:2N
  • 6Petersen P. Thromboembolic complications in atrial fibrillation[J]. Stroke, 1990,21:4
  • 7The AFFIRM investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation[J]. N Engl J Med, 2002,347:1 825
  • 8马长生,周玉杰,马煜,郑知刚,颜红兵,王勇,李霄,柯元南,汤旦林.北京地区非瓣膜病心房颤动患者缺血性脑卒中发生率及影响因素的随访研究[J].中华心血管病杂志,2002,30(3):165-167. 被引量:148
  • 9李庚山,吴宁,胡大一,黄从新,蒋文平,蔡乃绳.关于心房颤动病人治疗的建议[J].中国心脏起搏与心电生理杂志,2002,16(3):162-173. 被引量:96
  • 10戚文航.中国部分地区心房颤动住院病例回顾性调查[J].中华心血管病杂志,2003,31(12):913-916. 被引量:380

共引文献10

同被引文献18

  • 1李小鹰.老年心房颤动患者的抗血栓治疗[J].中华老年心脑血管病杂志,2005,7(2):73-75. 被引量:19
  • 2袁永,毛群,王广,张素红,勾俊龙.基底动脉系统梗死3例早期静脉尿激酶溶栓治疗价值分析[J].实用医学杂志,2006,22(11):1343-1344. 被引量:1
  • 3心房颤动抗栓研究协作组,胡大一,孙艺红,张鹤萍,姜立清.华法林对非瓣膜病心房颤动抗栓的安全性和有效性研究[J].中华内科杂志,2006,45(10):800-803. 被引量:64
  • 4陈伟平,黎锦如,莫建伟,李少兰,高广生,向绍通.急性脑梗死后血管性痴呆的颈动脉彩超研究[J].实用医学杂志,2007,23(13):2025-2027. 被引量:2
  • 5Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study [J]. Stroke,1991, 22(8): 983-8.
  • 6Furberg CD, Psaty BM, Manolio TA, et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)[J].Am J Cardiol, 1994, 74(3): 236-41.
  • 7Morley J, Marinchak R, Rials SJ, et al. Atrial fibrillation, anticoagulation, and stroke[J]. Am J Cardiol, 1996, 77(3): 38-44.
  • 8Waldo AL. New possibilities in anticoagulant management of atrial fibrillation[J]. Rev Cardiovasc Med, 2004, 5 (Suppl 5): 30-8.
  • 9Go AS, Hylek EM, Chang Y, et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: How well do randomized trials translate into clinical practice[J]? JAMA, 2003, 290(3): 2685-92.
  • 10Wolf P A, Abbott R D, Kannel W B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study [J]. Stroke, 1991,22(8) :983-988.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部